Loading…
RADICAVA ORS® (edaravone) is an oral suspension treatment for amyotrophic lateral sclerosis (ALS) evaluated across seven clinical trials. It is designed to slow the loss of physical function in ALS patients and is supported by a pharmacokinetic study and observational analysis.
We haven’t found Radicava HCP in the AI answers we’ve checked.
